These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34392518)

  • 1. The safety, efficacy, and cost-effectiveness of gentamycin-collagen sponge in multicomponent prevention strategy of cardiac implantable electronic device infections - a single-center experience.
    Kaczmarek K; Strzelecki A; Ptaszyński P; Wranicz JK; Cygankiewicz I
    Kardiol Pol; 2021; 79(10):1079-1085. PubMed ID: 34392518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of healthcare claims to validate the Prevention of Arrhythmia Device Infection Trial cardiac implantable electronic device infection risk score.
    Ahmed FZ; Blomström-Lundqvist C; Bloom H; Cooper C; Ellis C; Goette A; Greenspon AJ; Love CJ; Johansen JB; Philippon F; Tarakji KG; Holbrook R; Sherfesee L; Xia Y; Seshadri S; Lexcen DR; Krahn AD
    Europace; 2021 Sep; 23(9):1446-1455. PubMed ID: 33755136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of the antibacterial envelope to prevent cardiac implantable electronic device infection in a high-risk population.
    Chaudhry U; Borgquist R; Smith JG; Mörtsell D
    Europace; 2022 Dec; 24(12):1973-1980. PubMed ID: 35989511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with gentamicin-impregnated collagen sponges in reducing infection of implantable cardiac devices: 10-year analysis with propensity score matching.
    Matteucci A; Bonanni M; Massaro G; Chiricolo G; Stifano G; Forleo GB; Biondi-Zoccai G; Sangiorgi G
    Rev Port Cardiol; 2023 Aug; 42(8):711-717. PubMed ID: 37085085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposal for a Novel Score to Determine the Risk of Cardiac Implantable Electronic Device Infection.
    Calderón-Parra J; Sánchez-Chica E; Asensio-Vegas Á; Fernández-Lozano I; Toquero-Ramos J; Castro-Urda V; Royuela-Vicente A; Ramos-Martínez A
    Rev Esp Cardiol (Engl Ed); 2019 Oct; 72(10):806-812. PubMed ID: 30340923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The BLISTER Score: A Novel, Externally Validated Tool for Predicting Cardiac Implantable Electronic Device Infections, and Its Cost-Utility Implications for Antimicrobial Envelope Use.
    Maclean E; Mahtani K; Honarbakhsh S; Butcher C; Ahluwalia N; Dennis ASC; Creta A; Finlay M; Elliott M; Mehta V; Wijesuriya N; Shaikh O; Zaw Y; Ogbedeh C; Gautam V; Lambiase PD; Schilling RJ; Earley MJ; Moore P; Muthumala A; Sporton SCE; Hunter RJ; Rinaldi CA; Behar J; Martin C; Monkhouse C; Chow A
    Circ Arrhythm Electrophysiol; 2024 Mar; 17(3):e012446. PubMed ID: 38258308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic prophylaxis based on individual infective risk stratification in cardiac implantable electronic device: the PRACTICE study.
    Malagù M; Vitali F; Brieda A; Cimaglia P; De Raffele M; Tazzari E; Musolino C; Balla C; Serenelli M; Cultrera R; Rapezzi C; Bertini M
    Europace; 2022 Mar; 24(3):413-420. PubMed ID: 34487163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of an absorbable antibiotic envelope for prevention of cardiac implantable electronic device infection.
    Rennert-May E; Raj SR; Leal J; Exner DV; Manns BJ; Chew DS
    Europace; 2021 May; 23(5):767-774. PubMed ID: 33554239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative checklist to reduce the risk of cardiac implantable electronic device infections.
    Ziacchi M; Massaro G; Angeletti A; Statuto G; Diemberger I; Martignani C; Galiè N; Biffi M; Boriani G
    Pacing Clin Electrophysiol; 2022 Feb; 45(2):262-269. PubMed ID: 34927271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Stratifying and Prognostic Analysis of Subclinical Cardiac Implantable Electronic Devices Infection: Insight From Traditional Bacterial Culture.
    Lin G; Zou T; Dong M; Liu J; Cui W; Tong J; Shi H; Chen H; Chong J; Lyu Y; Wu S; Wang Z; Jin X; Gao X; Sun L; Qu Y; Yang J
    J Am Heart Assoc; 2021 Nov; 10(22):e022260. PubMed ID: 34729993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial Envelope to Prevent Cardiac Implantable Device Infection.
    Tarakji KG; Mittal S; Kennergren C; Corey R; Poole JE; Schloss E; Gallastegui J; Pickett RA; Evonich R; Philippon F; McComb JM; Roark SF; Sorrentino D; Sholevar D; Cronin E; Berman B; Riggio D; Biffi M; Khan H; Silver MT; Collier J; Eldadah Z; Wright DJ; Lande JD; Lexcen DR; Cheng A; Wilkoff BL;
    N Engl J Med; 2019 May; 380(20):1895-1905. PubMed ID: 30883056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of cardiac implantable electronic device infections: incidence and risk factors.
    Han HC; Hawkins NM; Pearman CM; Birnie DH; Krahn AD
    Europace; 2021 Jun; 23(23 Suppl 4):iv3-iv10. PubMed ID: 34051086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of changing antiseptic skin preparation agent used for cardiac implantable electronic device (CIED) procedures on the risk of infection.
    Qintar M; Zardkoohi O; Hammadah M; Hsu A; Wazni O; Wilkoff BL; Tarakji KG
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):240-6. PubMed ID: 25224666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Cardiac Implantable Electronic Device Infection: A Clinical and Economic Analysis of the WRAP-IT Trial.
    Wilkoff BL; Boriani G; Mittal S; Poole JE; Kennergren C; Corey GR; Love JC; Augostini R; Faerestrand S; Wiggins SS; Healey JS; Holbrook R; Lande JD; Lexcen DR; Willey S; Tarakji KG;
    Circ Arrhythm Electrophysiol; 2020 May; 13(5):e008280. PubMed ID: 32281393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of fibrotic capsule debridement during generator replacement on cardiac implantable electronic device infection risk.
    Goldenberg GR; Barsheshet A; Bishara J; Kadmon E; Omelchencko A; Strasberg B; Golovchiner G
    J Interv Card Electrophysiol; 2020 Jun; 58(1):113-118. PubMed ID: 31227978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health and Economic Outcomes Associated with Use of an Antimicrobial Envelope as a Standard of Care for Cardiac Implantable Electronic Device Implantation.
    Shariff N; Eby E; Adelstein E; Jain S; Shalaby A; Saba S; Wang NC; Schwartzman D
    J Cardiovasc Electrophysiol; 2015 Jul; 26(7):783-9. PubMed ID: 25845917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention and Management of Cardiac Implantable Electronic Device Infections: State-of-the-Art and Future Directions.
    Mahtani K; Maclean E; Schilling RJ
    Heart Lung Circ; 2022 Nov; 31(11):1482-1492. PubMed ID: 35989213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local gentamicin-collagen sponge reduces cardiovascular implantable electronic device infections and pocket hematoma.
    Monaco C; Barone L; Cammalleri V; Stifano G; Magliano G; Geuna F; Romeo F; Sergi D
    Eur Rev Med Pharmacol Sci; 2022 Jul; 26(14):5218-5224. PubMed ID: 35916820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic impact of introducing TYRX amongst patients with heart failure and reduced ejection fraction undergoing implanted cardiac device procedures: a retrospective model based cost analysis.
    Burnhope E; Rodriguez-Guadarrama Y; Waring M; Guilder A; Malhotra B; Razavi R; Rinaldi CA; Pennington M; Carr-White G
    J Med Econ; 2019 May; 22(5):464-470. PubMed ID: 30744444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased long-term mortality in patients with cardiovascular implantable electronic device infections.
    Rizwan Sohail M; Henrikson CA; Jo Braid-Forbes M; Forbes KF; Lerner DJ
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):231-9. PubMed ID: 25243484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.